Related Experiment Video
Updated: Jul 6, 2025
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Combining QSAR techniques, molecular docking, and molecular dynamics simulations to explore anti-tumor inhibitors
Yuan Liu1,2, Jian-Bo Tong1,2, Peng Gao1,2
1College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China.
Abstract:
Focal Adhesion Kinase (FAK) is an important target for tumor therapy and is closely related to tumor cell genesis and progression. In this paper, we selected 46 FAK inhibitors with anticancer activity in the pyrrolo pyrimidine backbone to establish 3D/2D-QSAR models to explore the relationship between inhibitory activity and molecular structure. We have established two ideal models, namely, the Topomer CoMFA model (= 0.715, = 0.984) and the Holographic Quantitative Structure-Activity Relationship (HQSAR) model (= 0.707, = 0.899). Both models demonstrate excellent external prediction capabilities.Based on the QSAR results, we designed 20 structurally modified novel compounds, which were subjected to molecular docking and molecular dynamics studies, and the results showed that the new compounds formed many robust interactions with residues within the active pocket and could maintain stable binding to the receptor proteins. This study not only provides a powerful screening tool for designing novel FAK inhibitors, but also presents a series of novel FAK inhibitors with high micromolar activity that can be used for further characterization. It provides a reference for addressing the shortcomings of drug metabolism and drug resistance of traditional FAK inhibitors, as well as the development of novel clinically applicable FAK inhibitors.
Insights
Researchers developed quantitative structure-activity relationship (QSAR) models to design novel Focal Adhesion Kinase (FAK) inhibitors for cancer therapy. These models identified promising new compounds with robust binding potential for further development.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Oncology
Background:
- Focal Adhesion Kinase (FAK) plays a crucial role in tumor development and progression, making it a significant therapeutic target.
- Developing effective FAK inhibitors is essential for advancing cancer treatment strategies.
Purpose of the Study:
- To establish robust 3D/2D-QSAR models for predicting the anticancer activity of pyrrolo pyrimidine-based FAK inhibitors.
- To explore the structure-activity relationships governing FAK inhibition.
- To design and evaluate novel FAK inhibitor candidates with improved properties.
Main Methods:
- Selection of 46 FAK inhibitors with anticancer activity.
- Establishment of Topomer CoMFA and Holographic Quantitative Structure-Activity Relationship (HQSAR) models.
- Molecular docking and molecular dynamics simulations for novel compound evaluation.
Main Results:
- Development of two validated QSAR models (Topomer CoMFA and HQSAR) with excellent predictive capabilities.
- Design of 20 novel pyrrolo pyrimidine derivatives exhibiting strong interactions within the FAK active site.
- Identification of compounds with stable binding affinities to receptor proteins.
Conclusions:
- The developed QSAR models serve as effective tools for designing novel FAK inhibitors.
- The study presents a series of promising FAK inhibitors with potential to overcome limitations of existing drugs, such as drug resistance and metabolism issues.
- These findings offer a valuable reference for the development of next-generation clinically applicable FAK inhibitors.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
